←Back to Expert Scholars
Translational Medicine / 转化医学CAR-T Design, Costimulation
Dario Campana
MD, PhD
🏢National University of Singapore🌐Singapore
Professor of Pediatrics
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dario Campana co-invented 4-1BB-based CD19 CAR-T constructs that became tisagenlecleucel and continues to develop CAR-NK and CAR-T therapies. His group at NUS has trained multiple cell therapy leaders. He previously led the St. Jude leukemia translational laboratory.
Share:
🧪Research Fields 研究领域
CAR-T design
4-1BB costimulation
CD19 CAR
NK cell therapy
leukemia immunotherapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Dario Campana 的研究动态
Follow Dario Campana's research updates
留下邮箱，当我们发布与 Dario Campana（National University of Singapore）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment